Works matching IS 03618609 AND DT 2015 AND VI 90 AND IP 2


Results: 22
    1

    Extramedullary Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 2, p. 100, doi. 10.1002/ajh.23880
    By:
    • Banwait, Ranjit;
    • Aljawai, Yosra;
    • Cappuccio, Joseph;
    • McDiarmid, Serena;
    • Morgan, Elizabeth A.;
    • Leblebjian, Houry;
    • Roccaro, Aldo M.;
    • Laubach, Jacob;
    • Castillo, Jorge J.;
    • Paba-Prada, Claudia;
    • Treon, Steven;
    • Redd, Robert;
    • Weller, Edie;
    • Ghobrial, Irene M.
    Publication type:
    Article
    2
    3

    Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 2, p. 144, doi. 10.1002/ajh.23882
    By:
    • Hamilton, Betty K.;
    • Rybicki, Lisa;
    • Dean, Robert;
    • Majhail, Navneet S.;
    • Haddad, Housam;
    • Abounader, Donna;
    • Hanna, Rabi;
    • Sobecks, Ronald;
    • Duong, Hien;
    • Hill, Brian T.;
    • Copelan, Edward;
    • Bolwell, Brian;
    • Kalaycio, Matt
    Publication type:
    Article
    4
    5
    6

    Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone ( MOp AD) in patients with relapsed/refractory acute lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 2, p. 120, doi. 10.1002/ajh.23886
    By:
    • Kadia, Tapan M.;
    • Kantarjian, Hagop M.;
    • Thomas, Deborah A.;
    • O'Brien, Susan;
    • Estrov, Zeev;
    • Ravandi, Farhad;
    • Jabbour, Elias;
    • Pemmaraju, Naveen;
    • Daver, Naval;
    • Wang, Xuemei;
    • Jain, Preetesh;
    • Pierce, Sherry;
    • Brandt, Mark;
    • Garcia-Manero, Guillermo;
    • Cortes, Jorge;
    • Borthakur, Gautam
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Minimal residual disease as biomarker for optimal biologic dosing of ARA- C in patients with acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 2, p. 125, doi. 10.1002/ajh.23893
    By:
    • Maurillo, Luca;
    • Buccisano, Francesco;
    • Piciocchi, Alfonso;
    • Del Principe, Maria Ilaria;
    • Sarlo, Chiara;
    • Di Veroli, Ambra;
    • Panetta, Paola;
    • Irno-Consalvo, Maria;
    • Nasso, Daniela;
    • Ditto, Concetta;
    • Refrigeri, Marco;
    • De Angelis, Gottardo;
    • Cerretti, Raffaella;
    • Arcese, William;
    • Sconocchia, Giuseppe;
    • Lo-Coco, Francesco;
    • Amadori, Sergio;
    • Venditti, Adriano
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Hemoglobin C disease.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 2, p. 174, doi. 10.1002/ajh.23915
    By:
    • Bain, Barbara J.
    Publication type:
    Article